Health news simplified & rediscovered
Among more than 4,000 women diagnosed with breast cancer when most were in their 60s or older, those who got regular exercise in the five years before diagnosis were up to 37% less likely than more sedentary women to develop and die of cardiovascular disease in the decade after diagnosis. And the more exercise they […]
Continue Reading
Scientists are experimenting with various techniques to achieve targeted delivery and controlled release of anti-cancer drugs. In a recent study, researchers at the Indian Institute of Technology Bombay (IIT Bombay) have used a protein derived from the serum of cows, called bovine serum albumin (BSA), in a saline solution, to make a hydrogel that acts […]
Continue Reading
The study was done by Yool Lee, Amita Sehgal, and colleagues at the University of Pennsylvania. The results provide mechanistic support for ‘chronotherapy,’ the delivery of cancer drugs timed to the endogenous circadian rhythm. Circadian rhythms regulate many aspects of physiology from the organismic to the subcellular levels. Disruption of circadian rhythms, whether through jet […]
Continue Reading
Recently, the NPPA had capped trade margin of 42 non-scheduled anti-cancer drugs by 30 per cent. The National Pharmaceutical Pricing Authority (NPPA) has issued the order on March 14 directing the manufacturer to furnish the details. The manufacturers will have to submit the landing cost by March 15 with the NPPA. Providing major relief to […]
Continue Reading
While the central government is considering this move certain patient’s rights organisation such as Cure SMA Foundation of India, Lysosomal Storage Disorder Support Society (LSDSS), Mr Kishori Lal, a cancer patient, and All India Drug Action Network (AIDAN) have come forward to point out flaws in the government’s plan. A joint statement released by them […]
Continue Reading
In recent years, scientists have been testing a new class of cancer drugs. They target a specific molecular pathway that has been shown to be faulty in many types of cancer. Specifically, these drugs target a cell signalling pathway called phosphatidylinositol-3 kinase (PI3K), which is activated by insulin. Previous studies have shown that mutations in […]
Continue Reading
Existing cancer drugs could be repurposed as treatments for vascular inflammation, according to new research from the University of California San Diego School of Medicine Vascular inflammation (inflammation of the blood vessels) is a significant contributing factor in the early phases of atherosclerosis, a disease whereby plaque builds up inside the arteries and which can […]
Continue Reading
Within tumours, large portions are deprived of oxygen. Scientists know that these hypoxic regions tend to be the most resistant to treatment. If a cell is unable to access adequate oxygen, it slows down and enters what is known as a quiescent state. The molecular switch mTORC1 is responsible for assessing the situation before telling […]
Continue ReadingThe 86 cancer patients were a disparate group, with tumours of the pancreas, prostate, uterus or bone. One woman had a cancer so rare there were no tested treatments. She was told to get her affairs in order. Still, these patients had a few things in common. All had advanced disease that had resisted every […]
Continue Reading